Global Psoriasis Treatment Market Report and Forecast 2024-2032

Global Psoriasis Treatment Market Outlook

The global psoriasis treatment market value was USD 28.54 billion in 2023, driven by the increasing prevalence of psoriasis across the globe. The market size is anticipated to grow at a CAGR of 9.2% during the forecast period of 2024-2032 to achieve a value of USD 63.18 billion by 2032.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The Increasing Prevalence of Psoriasis Disease is Augmenting the Market Growth of Psoriasis Treatment

The global market for psoriasis treatment is being driven by increasing incidences of psoriasis due to certain genetic or environmental factors, thereby augmenting the demand for effective treatment and hence stimulating the growth of the market.

According to the World Health Organisation, the reported prevalence of psoriasis in countries range from 0.09% to 11.4%, making it a serious global problem. A combination of topical and systematic therapies to reduce the effects of psoriasis is a lifelong treatment aimed at remission, has been driving the growth of the market. Thus, robust investments towards the development of advanced treatment methods to control the spread of psoriasis disease are aiding the market growth.

Psoriasis Treatment: Market Segmentation

Psoriasis refers to a common inflammatory condition in which skin cells build up and form scales and itchy, dry patches. Treatment such as topical ointments, light therapy, and medication aims to remove scales and stop the robust growth of skin cells.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

On the basis of drug class, the market can be divided into:

• TNF Inhibitors 
• Interleukins
• Others

Based on type, the market can be categorised into:

• Plaque Psoriasis
• Psoriatic Arthritis
• Others

The market, based on route of administration, can be segmented into:

• Oral
• Parenteral 
• Topical

On the basis of distribution channel, the market can be classified into:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

The EMR report looks into the regional markets of psoriasis treatment like North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Robust Research and Development (R&D) for the Development of Effective Treatments to Propel the Market Growth

The growth in the global market for psoriasis treatment is expected to be determined by the rising awareness regarding the negative impact of the disease. Since the exact reason for the psoriasis disease is unknown, robust research and development (R&D) about the cause, potential effects, and effective treatments is expected to have a significant influence over the growth of the market. In addition to this, favourable government measures such as reimbursement schemes, subsidised treatments, and other thoughtful measures are also expected to boost the market growth. Moreover, the market is further projected to grow due to the presence of an extensive distribution channel, including retail and hospital pharmacies and online channels, which aid in the easy availability of the medication. Hence, these factors are anticipated to bolster the overall market growth of psoriasis treatment.

Key Industry Players in the Global Psoriasis Treatment Market

The report presents a detailed analysis of the following key players in the global psoriasis treatment market, looking into their capacity, market share, and latest developments like capacity expansions, plant turnabouts and mergers and acquisitions:

• AbbVie Inc.
• Novartis AG 
• Johnson and Johnson Services, Inc.
• Pfizer Inc. 
• Merc and Co., Inc. 
• Others

The comprehensive report looks at the micro and macro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of the Porter’s Five Forces Model.

Key Highlights of the Report